|
⚲
|
| Keyboard |
| Bashan Dror
✚
|
|
|---|---|
| CIK # | 0001781450 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001781450] | |
| 4 | [0001781450] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Bashan Dror | |
| Protalix BioTherapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Protalix BioTherapeutics Inc PLX
Common Stock
|
2025-12-19 | Buy | 56,000 | $1.81 | 101,360 |
|
Protalix BioTherapeutics Inc PLX
Common Stock
|
2024-04-01 | Grant | 263,960 | ||
|
Protalix BioTherapeutics Inc PLX
Common Stock
|
2023-10-19 | Buy | 48,387 | $1.40 | 67,742 |
|
Protalix BioTherapeutics Inc PLX
Common Stock
|
2023-10-19 | Buy | 16,129 | $1.41 | 22,742 |
|
Protalix BioTherapeutics Inc PLX
Common Stock
|
2023-08-15 | Grant | 800,000 | ||
|
Protalix BioTherapeutics Inc PLX
Stock Options (Right to Buy) · derivative
|
2022-09-07 | Grant | 750,000 | $0.00 | |
|
Protalix BioTherapeutics Inc PLX
Common Stock
|
2022-04-11 | Buy | 68,000 | $1.50 | 102,000 |
|
Protalix BioTherapeutics Inc PLX
Common Stock
|
2022-02-25 | Grant | 637,531 | ||
|
Protalix BioTherapeutics Inc PLX
Common Stock
|
2020-08-11 | Grant | 447,927 | ||
|
Protalix BioTherapeutics Inc PLX
Stock Options (Right to Buy) · derivative
|
2019-06-30 | Grant | 1,600,000 | $0.00 |